Mesothelioma News Monitoring Service

"Optimize complex discovery, biomarker validation & clinical translation to develop complement inhibition for rare and common diseases" With the only approved complement therapeutic, Soliris, on the market for over a decade, the industry is overflowing with companies in clinical translation in a race for the next approval. The 2nd Complement-based Drug Development Summit encapsulates this excitement and provides one platform for every leading complement company to network and learn in an effort to overcome common challenges including: Create Translatable Complement Assays: Explore the need for a standardized assay to minimize variation between labs and accurately determine clear and reliable clinical comparisons. Identify which Common Indication will Benefit Most: As the ...

Presidents: Prof. Gian Carlo di Renzo Prof. Roberto Romero TOPICS: DEFINITION, DIAGNOSIS AND MONITORING OF NORMAL TERM LABOR- PART 1 DEFINITION, DIAGNOSIS AND MONITORING OF NORMAL TERM LABOR – PART 2 THE SECOND STAGE OF LABOR INDUCTION AND ACCELERATION OF LABOUR OPERATIVE DELIVERY THE PELVIC FLOOR CESAREAN DELIVERY: THE MOST COMMON OPERATION IN THE WORLD POSTPARTUM HEMORRHAGE, PLACENTAL IMPLANTATION DISORDERS AND SPECIAL CHALLENGES UNDERSTANDING THE MECHANISMS OF DISEASE : PART 1 UNDERSTANDING THE MECHANISMS OF DISEASE : PART 2 PRETERM PREMATURE RUPTURE OF MEMBRANES PREDICTION OF PRETERM LABOR AND BIRTH PREVENTION MANAGEMENT OF ACUTE PRETERM LABOR

R&D scientists are often at a disadvantage when working in process research and development because of their lack of knowledge about the basic principles of chemical engineering, and the impact of decisions regarding process yield and selectivity on up- and downstream operations. Other branches of engineering face a similar disadvantage when considering the whole process. This course has been developed, and is presented, by chemical engineers and chemists who specialise in facilitating knowledge transfer and understanding between different scientific and engineering disciplines working at the R&D-manufacturing interface. As a result, it does not dwell on the derivation of mathematical formulae or equations used in chemical engineering design, but instead focuses on what other ...

This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S. Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval. Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, ...

The 14th Annual Personalized Medicine Conference at Harvard Medical School will examine where new scientific developments in personalized medicine meet with still evolving policies and practices around the world, presenting both challenges and opportunities for the field. As the sessions will demonstrate, targeted therapies, highly personalized one-time treatments, and newly conceived diagnostic paradigms now help us predict, prevent, and treat disease in previously unimaginable ways, and artificial intelligence may soon give us the ability to refine and augment our ability to implement medical interventions at exactly the right time and in exactly the right way. But many public officials have only just begun to consider the policies necessary to ensure that these new treatments and ...

Deliver customer experience through innovative technology and omni-channel strategy. Break down the model you need to raise the bar on customer experience and get ROI on marketing strategies. You’ll get case studies that show practical steps of how innovation in chatbots, voice search, augmented reality and artificial intelligence can radically transform your ability to engage the customer. To execute omni-channel marketing you need strategy to support your technology selection. This two day conference will evaluate methods to scale innovation in pharma, incentivization structures to align your teams to CX and training tactics to encourage empathetic user-centered design that puts the customer at the center. • Engage your customer with omni-channel strategy • Great customer ...

The International Paediatric Medical Congress has been designed to address most of the burning issues in the field of paediatrics. The congress will bring together groups of interdisciplinary experts who will focus on the practical management and the latest evidence-based clinical data on key challenges faced by paediatricians in the region and the most effective strategies designed to overcome these challenges. The congress will feature interactive case-studies, panel discussions, educational workshops, networking sessions and platform presentations on current issues of Paediatrics including Paediatric Gastroenterology, Infectious Diseases, Critical Care and Emergencies, Cardiology and Paediatrics Neurodevelopment Disorders. Prices : USD 499-2,399

After the success of last year, SMi is delighted to announce the return of Lyophilization USA Conference to New Jersey, USA, taking place on November 15th - 16th 2018. This year's event will focus on providing attendees with the latest technological advancements in lyophilization. 16% of the top 100 pharmaceutical drugs and 35% of biologic drugs are lyophilized, and with more than 30% of the FDA-approved parenterals lyophilized and soon more than half of injectable drugs to require lyophilization, there’s a need for standardization and expansion of the lyophilization process in pharmaceuticals. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products. 2018 Event Highlights: • Discover novel ...

Through didactic presentations and case-based discussions, our expert faculty will help you navigate the key issues in managing the baseball athlete. They’ll offer practical solutions based on their experience to help you deal with shoulder, elbow, core, hip, and foot and ankle injuries. Plus, they’ll be available throughout the meeting to answer all your questions. This course is open to orthopaedic surgeons, physicians, athletic trainers, physical therapists, strength and conditioning experts, or coaches concerned with the management or prevention of injuries to the baseball athlete. Upon completion of this course, learners will be able to: • Analyze epidemiological trends in baseball injuries for professional, collegiate, and youth baseball • Integrate prevention strategies ...